Last $3.55 USD
Change Today +0.06 / 1.72%
Volume 27.6K
AXGN On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ CM
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

axogen inc (AXGN) Snapshot

Open
$3.40
Previous Close
$3.49
Day High
$3.69
Day Low
$3.40
52 Week High
02/4/14 - $4.68
52 Week Low
08/12/14 - $2.11
Market Cap
62.0M
Average Volume 10 Days
19.9K
EPS TTM
$-0.88
Shares Outstanding
17.5M
EX-Date
01/27/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AXOGEN INC (AXGN)

Related News

No related news articles were found.

axogen inc (AXGN) Related Businessweek News

No Related Businessweek News Found

axogen inc (AXGN) Details

AxoGen, Inc. operates as a medical technology company. It focuses on advancing the science and commercialization of peripheral nerve repair solutions. It offers a range of surgical nerve repair solutions, including Avance Nerve Graft, a processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa ExtraCellular Matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. The company’s products are used by plastic reconstructive surgeons, and orthopedic and plastic surgeons during surgical interventions to repair various nerve injuries. It procures and processes its tissue products in the United States, Canada, Italy, Austria, the United Kingdom, the Netherlands, Israel, and Switzerland. AxoGen, Inc. is headquartered in Alachua, Florida.

73 Employees
Last Reported Date: 03/6/14

axogen inc (AXGN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $314.5K
Senior Vice President of Business Development...
Total Annual Compensation: $251.6K
Senior Vice President of Sales
Total Annual Compensation: $314.6K
Chief Marketing Officer
Total Annual Compensation: $231.1K
Compensation as of Fiscal Year 2013.

axogen inc (AXGN) Key Developments

AxoGen, Inc. Announces Promotion of Jill Schiaparelli to Chief Marketing Officer

AxoGen, Inc. has announced the promotion of Jill Schiaparelli to the role of chief marketing officer. In this position Schiaparelli will focus on the strategy to develop current and expansion nerve repair markets as well as brand and corporate marketing. Ms. Schiaparelli joined AxoGen in February of 2012 as the Senior vice president of Business Strategy and Marketing, bringing more than 20 years of experience in strategic marketing and commercialization for advanced medical technologies including creation of markets for disruptive products.

AxoGen, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

AxoGen, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenues of $4,671,340 compared to revenue of $2,957,462 for the same period a year ago. Loss from operations was $1,802,904 compared to $2,276,994 last year. Net loss was $3,238,174 or $0.19 per basic and diluted share compared to $3,552,781 or $0.25 per basic and diluted share last year. For the nine months, the company reported revenues of $12,023,789 compared to revenue of $7,962,683 for the same period a year ago. Loss from operations was $7,091,791 compared to $6,794,877 last year. Net loss was $11,219,210 or $0.64 per basic and diluted share compared to $10,448,090 or $0.86 per basic and diluted share last year. Net cash used for operating activities was $8,019,485 compared to $8,061,343 last year. Purchase of property and equipment was $342,875 compared to $66,564 last year. Acquisition of intangible assets was $39,454 compared to $50,262 last year.

AxoGen, Inc. to Report Q3, 2014 Results on Nov 13, 2014

AxoGen, Inc. announced that they will report Q3, 2014 results After-Market on Nov 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AXGN:US $3.55 USD +0.06

AXGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $71.43 USD -0.83
Integra LifeSciences Holdings Corp $57.09 USD +0.11
Stryker Corp $92.70 USD -0.67
View Industry Companies
 

Industry Analysis

AXGN

Industry Average

Valuation AXGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AXOGEN INC, please visit www.axogeninc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.